Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3 in the site footer, reflecting a minor ClinicalTrials.gov software/content-display update rather than any change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:35:53.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2. No visible changes to the study record content are indicated.
    Difference
    0.0%
    Check dated 2026-04-17T02:44:36.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    B-cell chronic lymphocytic leukemia was added to the list of conditions described on the study page.
    Difference
    0.1%
    Check dated 2026-04-02T15:40:51.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision labels updated from v3.4.3 to v3.5.0. No visible changes to study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-03-19T05:25:54.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:52:47.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The funding-lapse notice and the prior Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:26.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.